2 Results for "

diabetic retinopathy (DR)

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "diabetic retinopathy (DR)" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-139170
CAS No.: 2247240-76-0
Purity:  99.77%
Target:  

ROCK

Research Areas:  

Metabolic Disease

CAY10746 is a selective Rho kinase (ROCK) inhibitor. CAY10746 has inhibitory activity for ROCK I, ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively. CAY10746 can be used for the research of diabetic retinopathy (DR) .
loading...
    loading...
Cat. No.: HY-150069
CAS No.: 2271269-01-1
Purity:  99.16%
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Metabolic Disease

UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy (DR) .
loading...
    loading...